ZA202202320B - Oral pharmaceutical composition containing heterocyclic compound - Google Patents
Oral pharmaceutical composition containing heterocyclic compoundInfo
- Publication number
- ZA202202320B ZA202202320B ZA2022/02320A ZA202202320A ZA202202320B ZA 202202320 B ZA202202320 B ZA 202202320B ZA 2022/02320 A ZA2022/02320 A ZA 2022/02320A ZA 202202320 A ZA202202320 A ZA 202202320A ZA 202202320 B ZA202202320 B ZA 202202320B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- composition containing
- heterocyclic compound
- containing heterocyclic
- oral pharmaceutical
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000002459 sustained effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2019/031895 WO2021029020A1 (ja) | 2019-08-13 | 2019-08-13 | 経口医薬組成物 |
| PCT/JP2020/030777 WO2021029430A1 (ja) | 2019-08-13 | 2020-08-13 | 複素環化合物を含有する経口医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202202320B true ZA202202320B (en) | 2024-06-26 |
Family
ID=74569440
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2022/02320A ZA202202320B (en) | 2019-08-13 | 2022-02-23 | Oral pharmaceutical composition containing heterocyclic compound |
| ZA2022/02319A ZA202202319B (en) | 2019-08-13 | 2022-02-23 | Oral pharmaceutical composition |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2022/02319A ZA202202319B (en) | 2019-08-13 | 2022-02-23 | Oral pharmaceutical composition |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20220273647A1 (https=) |
| EP (2) | EP4015001A4 (https=) |
| JP (7) | JPWO2021029020A1 (https=) |
| KR (2) | KR20220046624A (https=) |
| CN (2) | CN114222575A (https=) |
| AU (2) | AU2020328351B2 (https=) |
| BR (2) | BR112022002433A2 (https=) |
| CA (2) | CA3150827A1 (https=) |
| IL (2) | IL290469B2 (https=) |
| MX (3) | MX2022001758A (https=) |
| MY (2) | MY208261A (https=) |
| PH (2) | PH12022550349B1 (https=) |
| TW (2) | TWI870441B (https=) |
| WO (3) | WO2021029020A1 (https=) |
| ZA (2) | ZA202202320B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2021029020A1 (https=) * | 2019-08-13 | 2021-02-18 | ||
| CN118742293A (zh) * | 2022-01-31 | 2024-10-01 | 住友精化株式会社 | 药物控释制剂用组合物和药物控释制剂 |
| JP2023173950A (ja) * | 2022-05-27 | 2023-12-07 | 同仁医薬化工株式会社 | 経口液剤 |
| CN120936353A (zh) * | 2023-03-29 | 2025-11-11 | 默沙东有限责任公司 | 控释pde10a制剂 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2799241A (en) | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
| US3173876A (en) | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
| NL271831A (https=) | 1960-11-29 | |||
| US3276586A (en) | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
| US3546142A (en) | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
| US3541006A (en) | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
| US3541005A (en) | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
| US3865108A (en) | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4002173A (en) | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
| GB1478759A (en) | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
| US4207893A (en) | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
| JP4315393B2 (ja) | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP4540700B2 (ja) * | 2006-10-13 | 2010-09-08 | 大塚製薬株式会社 | 医薬 |
| TWI636784B (zh) * | 2011-04-05 | 2018-10-01 | 大塚製藥股份有限公司 | 含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組，以及彼之用途 |
| JO3753B1 (ar) * | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
| TWI679977B (zh) * | 2011-10-19 | 2019-12-21 | 大塚製藥股份有限公司 | 口服溶液 |
| AR090775A1 (es) * | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | Preparado inyectable |
| CN112402421A (zh) * | 2012-10-25 | 2021-02-26 | 大塚制药株式会社 | 含有依匹唑派或其盐的预防和/或治疗剂 |
| CN106667969A (zh) * | 2017-02-23 | 2017-05-17 | 佛山市弘泰药物研发有限公司 | 一种依匹哌唑缓释胶囊及其制备方法 |
| JP6886654B2 (ja) | 2017-04-11 | 2021-06-16 | 学校法人帝京大学 | 抗カンジダ活性組成物 |
| JPWO2021029020A1 (https=) * | 2019-08-13 | 2021-02-18 |
-
2019
- 2019-08-13 JP JP2021539751A patent/JPWO2021029020A1/ja not_active Withdrawn
- 2019-08-13 WO PCT/JP2019/031895 patent/WO2021029020A1/ja not_active Ceased
-
2020
- 2020-08-13 MY MYPI2022000768A patent/MY208261A/en unknown
- 2020-08-13 KR KR1020227007743A patent/KR20220046624A/ko active Pending
- 2020-08-13 CN CN202080056806.6A patent/CN114222575A/zh active Pending
- 2020-08-13 JP JP2021539312A patent/JP7148733B2/ja active Active
- 2020-08-13 KR KR1020227007745A patent/KR20220046625A/ko active Pending
- 2020-08-13 CA CA3150827A patent/CA3150827A1/en active Pending
- 2020-08-13 IL IL290469A patent/IL290469B2/en unknown
- 2020-08-13 WO PCT/JP2020/030776 patent/WO2021029429A1/ja not_active Ceased
- 2020-08-13 US US17/634,758 patent/US20220273647A1/en not_active Abandoned
- 2020-08-13 CN CN202080056803.2A patent/CN114222562A/zh active Pending
- 2020-08-13 CA CA3150751A patent/CA3150751A1/en active Pending
- 2020-08-13 PH PH1/2022/550349A patent/PH12022550349B1/en unknown
- 2020-08-13 TW TW109127608A patent/TWI870441B/zh active
- 2020-08-13 JP JP2021539311A patent/JP7110495B2/ja active Active
- 2020-08-13 MY MYPI2022000781A patent/MY208267A/en unknown
- 2020-08-13 AU AU2020328351A patent/AU2020328351B2/en active Active
- 2020-08-13 EP EP20853189.7A patent/EP4015001A4/en active Pending
- 2020-08-13 US US17/634,791 patent/US20220280418A1/en not_active Abandoned
- 2020-08-13 MX MX2022001758A patent/MX2022001758A/es unknown
- 2020-08-13 BR BR112022002433A patent/BR112022002433A2/pt unknown
- 2020-08-13 AU AU2020327792A patent/AU2020327792B2/en active Active
- 2020-08-13 TW TW109127609A patent/TWI870442B/zh active
- 2020-08-13 BR BR112022002436A patent/BR112022002436A2/pt unknown
- 2020-08-13 EP EP20853069.1A patent/EP4015002A4/en active Pending
- 2020-08-13 PH PH1/2022/550347A patent/PH12022550347A1/en unknown
- 2020-08-13 MX MX2022001759A patent/MX2022001759A/es unknown
- 2020-08-13 WO PCT/JP2020/030777 patent/WO2021029430A1/ja not_active Ceased
-
2022
- 2022-02-09 IL IL290472A patent/IL290472A/en unknown
- 2022-02-10 MX MX2025006039A patent/MX2025006039A/es unknown
- 2022-02-23 ZA ZA2022/02320A patent/ZA202202320B/en unknown
- 2022-02-23 ZA ZA2022/02319A patent/ZA202202319B/en unknown
- 2022-07-13 JP JP2022112389A patent/JP2022132411A/ja active Pending
- 2022-09-21 JP JP2022150733A patent/JP7635187B2/ja active Active
-
2024
- 2024-08-26 US US18/815,060 patent/US20250127776A1/en active Pending
- 2024-09-18 US US18/888,277 patent/US20250057835A1/en active Pending
-
2025
- 2025-02-12 JP JP2025020427A patent/JP2025072595A/ja active Pending
- 2025-02-25 JP JP2025027501A patent/JP2025074104A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202202320B (en) | Oral pharmaceutical composition containing heterocyclic compound | |
| EP4685160A3 (en) | Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
| EP4512394A3 (en) | Dosage forms and use thereof | |
| MX2021002640A (es) | Formas morficas de los inhibidores del factor d del complemento. | |
| PH12021550687A1 (en) | Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt | |
| ECSP045238A (es) | Forma de dosis oral que contiene un inhibidor de pde 4 como un ingrediente activo y polivinilpirrolidona como excipiente | |
| PH12018501001A1 (en) | Therapeutic compositions for treatment of human immunodeficiency virus | |
| AU2018231044A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
| MX386033B (es) | Agente terapéutico para enfermedades hepáticas. | |
| EP3946547A4 (en) | DEVICES AND METHODS FOR DELIVERING PHARMACEUTICAL COMPOSITIONS | |
| PH12020550815A1 (en) | Delayed release deferiprone tablets and methods of using the same | |
| PH12022551468A1 (en) | Compounds active towards nuclear receptors | |
| JOP20190198B1 (ar) | تركيبة صيدلانية تشتمل على عامل مضاد للصفيحات ومثبط إفراز حمض معدي | |
| MX2022007265A (es) | Compuestos activos frente a receptores nucleares. | |
| NO20071806L (no) | Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel. | |
| MX391191B (es) | Composiciones de liberación extendida de onapristona y métodos. | |
| EA202190317A1 (ru) | Лекарственный препарат для наружного применения | |
| MX2018000963A (es) | Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol. | |
| JOP20230099A1 (ar) | تركيبات صيدلية | |
| PH12020550456A1 (en) | Alcohol-resistant oral pharmaceutical compositions of lorazepam | |
| WO2016187595A3 (en) | Oral pharmaceutical composition of methylergonovine | |
| EA202090842A1 (ru) | Таблетки деферипрона с отсроченным высвобождением и способы их применения | |
| IN2014MU03782A (https=) | ||
| UA91282U (uk) | Фармацевтичний продукт, що має виражену антигестагенну дію | |
| IN2013MU03069A (https=) |